Proficio Capital Partners LLC Novo Nordisk A S Transaction History

Proficio Capital Partners LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$122.71 - $146.91 $10,798 - $12,928	-88 Reduced 4.26%	1,979 $282,000
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $181,441 - $217,965	2,067 New	2,067 $213,000
Q1 2023 Apr 19, 2023	BUY	$132.34 - $159.14 $15.3 Million - $18.4 Million	115,456 New	115,456 $18.4 Million
Q3 2019 Nov 13, 2019	SELL	$47.54 - $53.43 $82,149 - $92,327	-1,728 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$46.79 - $52.47 $7,767 - $8,710	166 Added 10.63%	1,728 $88,000
Q1 2019 May 13, 2019	SELL	$46.36 - $52.63 $42,326 - $48,051	-913 Reduced 36.89%	1,562 $82,000
Q4 2018 Feb 08, 2019	SELL	$41.54 - $47.25 $3,281 - $3,732	-79 Reduced 3.09%	2,475 $114,000
Q3 2018 Nov 13, 2018	SELL	$46.76 - $51.24 $1,496 - $1,639	-32 Reduced 1.24%	2,554 $120,000
Q2 2018 Aug 10, 2018	SELL	$44.29 - $50.42 $11,338 - $12,907	-256 Reduced 9.01%	2,586 $119,000
Q1 2018 May 14, 2018	BUY	$48.49 - $58.14 $5,624 - $6,744	116 Added 4.26%	2,842 $140,000
Q4 2017 Feb 09, 2018	BUY	$47.53 - $53.73 $6,891 - $7,790	145 Added 5.62%	2,726 $146,000
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $106,208 - $127,036	2,581	2,581 $124,000

1,953

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $230B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.